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Abstract
Background: Surgical treatment is the optimal strategy for managing intertrochanteric fractures as it allows for early
rehabilitation and functional recovery. The purpose of the study was to assess the cost-effectiveness of commonly used
cephalomedullary nails for the treatment of unstable intertrochanteric hip fractures.
Methods: A decision analytic model was developed from a US payer’s perspective using clinical data from a pairwise
meta-analysis of randomised controlled trials (RCTs) and comparative observational studies comparing the integrated
twin compression screw (ITCS) nail versus two single-screw or blade cephalomedullary nails [single lag screw (SLS) nail
and single helical blade (SHB) nail]. The model considered a cohort of 1000 patients with a mean age of 76, as reported
in the clinical studies over a 1-year time period. Cost data was obtained from the Center for Medicare and Medicaid
Services website and published literature and adjusted for inflation. One-way and probabilistic sensitivity analyses were
conducted to assess the effect of uncertainty in model parameters on model conclusions.
Results: The model estimated 0.546 quality-adjusted life years (QALYs) and 0.78 complications avoided by using the
ITCS nail and 0.455 QALYs and 0.67 complications avoided for the standard of care, using SLS or SHB nails. The cost per
patient was $34,336 for patients treated with an ITCS nail and $37,036 for patients treated with the standard of care
respectively, resulting in a cost saving of $2700 in favour of the ITCS nail. More savings were observed when the ITCS
nail was compared to the SHB ($3280 per patient) and SLS ($1652 per patient). The findings were robust to a range of
both one-way and the probabilistic sensitivity analyses.
Conclusion: In conclusion, the ITCS nail can be considered a cost saving intervention in patients undergoing
intertrochanteric fracture fixation with an intramedullary device. Clinicians and policy makers should be
encouraged to adopt healthcare technologies such as ITCS that will help them to provide quality healthcare
despite falling budgets.
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Background
Hip fractures are a major public health problem in terms
of patient morbidity, mortality and costs to health and
social care. The incidence of hip fractures increases expo-
nentially with age with approximately 90% of hip fractures
occurring in people older than 65 years [1] due to higher
rates of osteoporosis and falls in the elderly population [2].
As the population ages, the number of fractures is esti-
mated to increase from about 320,000 per year to 580,000
by 2040 in the USA with healthcare costs exceeding $10
billion per year [3–5] placing a huge financial burden on
patients, families, insurers, hospitals and governments. Fur-
thermore, in the USA, it is estimated that hip fractures ac-
count for approximately 14% of all fractures, but impart
nearly 70% of the acute hospital care costs associated with
fracture treatment [6]. The 1-year mortality for hip
fractures ranges from 14 to 36%, with 30% more deaths
observed than the age-matched population [4].
In 2010, in the European Union, there was an estimated
incidence of 600,000 incident hip fractures costing €20 bil-
lion. In Germany, the incidence of hip fractures is esti-
mated at 125,000 (152/100,000 inhabitants) cases per year
and costs related to hip fractures are estimated to be 2.8
billion EURO per year [7]. In the UK, the incidence of hip
fractures is estimated to be between 70,000 to 75,000 per
year, the annual cost is estimated to be over £2 billion and
the incidence is predicted to increase to 104,000 by 2025
[2, 8] leading to increasing pressure on the falling health-
care budgets.
Surgical intervention is deemed to be the definitive
treatment for hip fractures as it allows for early patient
mobilisation [9–11] and economic evaluations have con-
cluded that surgery for hip fracture is cost saving when
compared to non-surgical treatment [1]. Consequently, a
variety of surgical techniques and implants have been in-
troduced for the treatment of intertrochanteric fractures.
In particular, the use of cephalomedullary nail fixation has
been shown to deliver superior clinical outcomes relative
to sliding hip screws in patients with unstable fractures
[9–11]. With increasing pressures on healthcare budgets
in many healthcare systems, it is important to have robust
clinical and economic evidence on the performance of the
different cephalomedullary fixation nails to assist clinical
decision making and provide value to the patients and
payers.
An economic evaluation estimated the cost-effectiveness
of sliding hip screws compared with cephalomedullary
nails for patients with intertrochanteric hip fractures and
concluded that sliding hip screws were cost-effective in
stable fractures while cephalomedullary nails were cost sav-
ing in unstable fractures [12]. The cost-effectiveness of
cephalomedullary nails in unstable fractures is therefore
established in patients with intertrochanteric hip fractures.
However, it is unclear which among the cephalomedullary
nailing systems is the best option in this patient population.
Our study therefore aimed to compared three commonly
used cephalomedullary fixation nails, the integrated twin
compression screw (ITCS) nail (TRIGEN◊ INTERTAN
Smith & Nephew, Memphis, TN, USA) compared with a
single helical blade (SHB) nail (Proximal Femoral Nail
Antirotation (PFNA™) DePuy Synthes, Solothurn,
Switzerland) and a single lag screw (SLS) nail (Gamma3™;
Stryker, Schönkirchen, Germany) in the treatment of inter-
trochanteric fractures.
Methods
A decision analytic model was constructed in Microsoft
Excel 2016 (Microsoft Corporation, Redmond, WA, USA)
to estimate the expected total costs and health benefits
expressed in quality-adjusted life years (QALYs) between
cephalomedullary nails. The mean age of patients included
in the model was 76 years as reported in the studies that
were included in the meta-analysis. The model was
assessed over a 1-year time period as the majority of the
outcomes were reported at 1 year. The model is assessed
from the US payer’s perspective in particular the Center for
Medicare and Medicaid Services (CMS). We did not dis-
count the costs and benefits since the time horizon was
short and up to 1 year.
The outline of the decision tree used is shown in Fig. 1.
The Figure shows the branches for the ITCS strategy, and
there are similar branches for the standard of care strategy
although these have not been included in the figure. The
figure demonstrates that when patients enter into the
model, they may develop complications or die. The mod-
elled complications or health states are implant-related fail-
ures, non-unions, healed state and death. A proportion of
patients who experience complications are further exposed
to the risk of revision surgery to treat a complication which
may or may not be successful. For the patients who require
revision surgery, an additional risk of mortality associated
with the revision surgery was assumed in accordance with
published literature [12].
Clinical parameters used in the economic model
Data for this economic analysis were derived from the
individual meta-analysis comparing ITCS with SHB and
SLS cephalomedullary nails. We updated a published
meta-analysis that compared the ITCS with SHB nail
[13] by including studies that compared ITCS with SLS
nail [14–16]. Thus, the baseline data on complications,
i.e., implant-related failures, non-unions and revisions,
were taken from the event rates seen in the combined
SHB and SLS nail arms of the meta-analysis. The ITCS
nail treatment effect (odds ratios) was then applied in
the model taken from the same meta-analysis.
All patients were at risk of age adjusted all-cause
mortality which was obtained from US Life tables
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2014 [17]. Hip surgery is also known to be associated
with an increased risk of mortality, and therefore, the
increase in mortality due to hip surgery was modelled
using data which was obtained from a study by Swart
et al. [12]. Additional mortality for patients who had
revision surgery was included and taken from the
same study by Swart [12]. We assumed that any mor-
tality was independent of the implant nail used, and
therefore, no treatment effect on mortality was
applied. We adopted this approach because mortality
is likely to be influenced by other factors such as
comorbidities due to the age of these patients who
Fig. 1 Integrated twin compression screw (ITCS) nail compared with standard of care using a single lag screw or a single helical blade; cost-
effectiveness model structure
Table 1 Clinical parameters used in the economic model
Outcome Mean N Events No events Source
Implant failures 0.159 762 121 641 Updated Nherera 2018 [13]
Revisions 0.071 637 45 592
Non-unions 0.022 447 10 437
Outcome Mean Lower 95 CI Upper 95% CI SE Source
Mortality due to fractures 0.06 0.03 0.12 0.02 Swart 2014 [12]
Revision surgery mortality 0.06 0.0001 0.09 0.02
Health-related quality of life (utility data)
Utility for healed fracture 0.700 0.630 0.800 0.044 Swart 2014 [12]
Utility for revision 0.600 0.450 0.750 0.080
Effectiveness of integrated compression screw
Implant-related failures 0.15 0.09 0.24 0.25 Updated Nherera 2018 [13]
Revisions 0.31 0.17 0.56 0.30
Non-unions 0.54 0.17 1.66 0.58
Proportion of patients in nursing home
Nursing home 0.24 0.18 0.3 0.03 Gu 2016 [1]
The lower and upper values for revision utility and proportion of patients in nursing home were assumed to be 25% below and above the reported mean values
Abbreviations: CI confidence interval, SE standard error, N total number of patients for the outcome
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are treated using these implants. All clinical data used
in the model is shown in Table 1.
Rates of long-term nursing home care for patients fol-
lowing surgery were modelled using data from Gu et al.
[1], who conducted an economic analysis of surgical com-
pared to non-surgical treatment for displaced intracapsu-
lar and extracapsular hip fractures. Long-term nursing
home care in the surgical arm was 16% for patients aged
65 to 74 years old, 24% for patients 75 to 84 years old, and
48% for patients older than 85 years. The model used 24%
since the mean age of the cohort was 77 years.
Cost data used in the economic model
Cost data used in the reference case, and the ranges used
in sensitivity analysis are given in Table 2. The study used
the following inpatient ICD-9 diagnosis codes 820.0x,
820.1x, 820.2x and 820.3x to identify patients with extra-
capsular fractures. The average of Center for Medicare
and Medicaid Services Medicare Payments of Diagnostic
Related Groups (DRGs) 461, 462, 469,470,480–81 were
applied in the model. The costs of the cephalomedullary
nail implants for the base case model were based on mean
values reported in the Premier Database. The study by
Swart [12] assumed no difference in implant costs, and we
adopted the same assumption in this model. Costs of revi-
sion surgery, long-term nursing home and annual
follow-up costs following discharge from hospital were
obtained from a published study by Gu et al. [1] and were
adjusted for medical inflation to 2017 USD. We assumed
that follow-up costs were the same for both revision and
primary operations. Furthermore, we did not explicitly
model revision costs of a total hip replacement following
implant failure. The proportion of patients that ended up
in a nursing home was independent of the choice of the
implant used as there was no specific data by implant.
Health-related quality of life
The utility values which are used to estimate the
quality-adjusted life years (QALYs) were obtained from a
published economic evaluation by Swart [12]. Utility
values are between 0.0 for death and 1.0 for best possible
health. The reported utility scores for patients undergo-
ing a successful initial fixation of an intertrochanteric
fracture were reported to be 0.70 with lower and upper
values of 0.63–0.80. The utility loss following revision sur-
gery was estimated to be − 0.10 [12]. The utility values
were age adjusted as there is evidence to suggest that
health-related quality of life is negatively correlated with
age [18]. Utility data used in the model are shown in
Table 1.
Sensitivity analysis and sub-group analysis
We conducted both one-way and probabilistic sensi-
tivity analyses to address the uncertainty around base
case results for an adult with a mean age of 76 years.
One-way sensitivity analyses were carried out by vary-
ing one input parameter at a time, assigning a low
and high value and then evaluating the impact of that
variation upon the model results. Probabilistic sensi-
tivity analysis entails specifying a distribution for each
model parameter and then simultaneously selecting
values at random from those distributions using
Monte Carlo simulation. Data on the ranges used in
sensitivity analysis are shown in Table 1 for clinical
parameters and Table 2 for costs. We also conducted
sub-group analyses, and in particular, we considered
the comparators individually, i.e., single helical blade
nail and single lag screw nail.
Results
The base case analysis from the payer’s perspective
demonstrated that the ITCS nail was associated with
lower total mean costs per patient and improved clin-
ical outcomes compared to patients in the standard
of care (single helical blade and single lag screw)
group. The use of the ITCS nail is therefore a domin-
ant strategy, i.e., cheaper overall and results in better
clinical outcomes. Table 3 show the results of the
economic analysis. The estimated cost savings for the
ITCS nail compared to standard of care is estimated
to be $2700 per patient per year.
Table 2 Cost data used in the model
Cost centre Mean Lower value Upper value Source
Cost of surgery $18,058 $13,543 $22,572 CMSa
Cost of revision $37,036 $24,691 $49,382 Swart 2014 [12]
Annual post discharge costs $15,976 $7989 $18,259 Gu 2014 [1]
Costs of treating non-healed fractures $652 $489 $815 CMSa
Nursing home $91,971 $45,985 $137,956 Gu 2014 [1]
Cephalomedullary nail implant cost $3000 $1500 $4500 2016 Premierb database
The lower and upper cost values were assumed to be 50% above or below the reported mean cost
aCMS—Center for Medicare and Medicaid Services; https://www.cms.gov/
bhttps://www.premierinc.com/wpdm-package/research/
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Sensitivity analysis
A number of parameters were varied in the one-way
sensitivity analysis shown in Table 4. The results of the
one-way sensitivity analysis show that the ITCS nail
remained cost saving when different assumptions were
applied. In the base case model, we assumed that 24% of
patients will end up in a nursing home and that all pa-
tients will incur $15,006 annual follow-up costs to capture
the system costs. In sensitivity analysis, we assumed there
were no follow-up costs including no nursing home costs
to restrict the analysis to a hospital perspective. When this
hospital perspective was adopted, ITCS remained cost sav-
ing, saving the hospital $414 per patient. Probabilistic sen-
sitivity analysis demonstrated that the ITCS nail is 100%
cost saving as shown by a flat cost-effectiveness accept-
ability curve at different willingness to pay values (Fig. 2)
and Fig. 3 which is showing that all simulations are lo-
cated in the south west quadrant.
Sub-group analysis
For sub-group analysis, we separately analysed the results
of each of the single nail, SHB and SLS. Sub-group results
for the single helical blade and the single lag screw all
showed similar results to the combined results, see
Tables 5 and 6. More complications were avoided when
the ITCS nail was compared to the single helical blade
than when compared to the single lag screw device. When
compared to the single helical blade, the cost savings per
patient was estimated to be $3280. In contrast, when com-
pared to the single lag screw, the cost saving was $1652
per patient. Overall, the results of sensitivity and
sub-group analyses were in agreement in that the ITCS
nail always produced a cost-saving result and therefore
remained dominant when compared to the standard of
care.
Discussion
A number of surgical implants have been introduced for
the treatment of intertrochanteric fractures, including
cephalomedullary nails which have the benefit of allow-
ing early mobilisation and minimise the risk of morbidity
and mortality [3, 4]. Our study assessed the clinical and
cost-effectiveness of the ITCS nail compared to standard
of care, i.e., single lag screw nail or single helical blade
nail use in patients with intertrochanteric fractures. This
economic analysis demonstrated that the ITCS nail
has advantages when compared to standard of care,
offering fewer complications as measured by
implant-related failures and revisions, but also cost
savings of $2700 per patient from the payer’s perspec-
tive. These results were tested in sensitivity analysis
and remained robust under various assumptions even
when follow-up and nursing home costs were re-
moved from the analysis, saving the hospital $414 per
patient. Furthermore, the probabilistic sensitivity ana-
lysis increased our confidence in these findings with a
100% probability that the ITCS nail was cost saving
at a threshold of $50,000/QALY.
We are not aware of any published cost-effectiveness
studies that have compared different cephalomedullary
nail fixation devices, although economic studies have
been performed comparing cephalomedullary nail
Table 3 Base case results
Intervention Costs Complications avoided QALYs Cost savings
Standard of care $37,036 0.67 0.455
Integrated compression screw $34,336 0.78 0.546 $2700
Abbreviation: QALYs quality-adjusted life years
Table 4 Sensitivity analysis: the ITCS nail compared to standard of care
Input parameter-mean (lower and upper value) Savings when lower value is used Savings when upper value is used
Effect on implant failures 0.31 (0.17–0.56) $2883 $2427
Effect on revisions 0.15 (0.09–0.24) $2708 $2687
Effect on non-unions 0.54 (0.17–1.66) $2593 $3026
Mortality due to fractures 0.06 (0.03–0.12) $3083 $1168
Revision surgery mortality 0.06 (0–0.09) $2700 $2700
Proportion in nursing home 0.24 (0.18–0.30) $2095 $4314
Cost of surgery $18,058 ($13,543–$22,572) $2700 $2700
Cost of revision $37,036 ($27,777–$45,295) $2620 $2781
Annual post discharge costs $15,976 ($11,982–$19,970) $2734 $2667
Cost of implants $3000 ($1500–$4500) $2684 $2717
Nursing home costs $91,971 ($45,985–$137956) $1490 $3911
Removing nursing home and follow-up costs $414
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fixation with sliding hip screws. These studies found that
cephalomedullary nail fixation was cost-effective for
unstable fractures [12]. Our study has gone a step fur-
ther and compared different cephalomedullary fixation
nails making it the first paper of its kind to compare the
ITCS nail to standard of care in this patient population.
Furthermore, our study is supported by robust clinical
evidence based on a meta-analysis that included both
observational and randomised controlled trials. The use
of both observational and randomised controlled trials
(RCTs) ensures that no useful evidence is discarded;
thus, all available evidence is incorporated into the
Fig. 2 Integrated twin compression screw (ITCS) nail compared with standard of care using a single lag screw or a single helical blade; cost-effectiveness
acceptability curves
Fig. 3 Integrated twin compression screw nail (ITCS) compared with standard of care using a single lag screw or a single helical blade;
cost-effectiveness plane
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analysis. The single helical blade comparison had been
evaluated in six studies, two RCTs [19, 20] and four
[21–24] observational studies while the single lag screw
analysis was evaluated in three studies, two RCTs [14,
15] and one observational study [16].
Our model made a number of conservative assump-
tions. We assumed revision was done with the same
implant, and we did not explicitly model the progression
of patients to total hip arthroplasty (THA). In reality, it
is possible that patients who need a reoperation to treat
failed internal fixation may end up with a conversion to
a THA within the first year. This information on the
conversion rates is not well characterised in the litera-
ture in relation to cephalomedullary nails in this popula-
tion. This assumption is therefore biased against the
implant with better revision rates, and the model may
need updating once such information becomes more
readily available. There are some subtle distinctions
between the implants such as the amount of bone loss
due to large entry portals in the greater trochanter
which have not been captured in the model. However,
these small differences are unlikely to result in a change
of the overall model conclusions as the potential impact
of these procedure-related events are already captured
within the reported clinical outcomes for the nails.
Our analysis also assumed that all of the cephalome-
dullary nails had an equal impact on the proportion of
patients who ended up in a nursing home. This assump-
tion is conservative and favours the implants with a
higher proportion of implant failure rates. The higher
the proportion of implant failure, the more chances of
requiring revision operations, which in turn may in-
crease the chances of dependency. In this case, we may
have underestimated the full potential savings of inte-
grated twin compression screw nail which had superior
revision and implant-related failure rates. This assertion
was confirmed in sensitivity analysis when it was as-
sumed that more patients in the standard of care group
needed nursing home care. We noted more savings as
opposed to the base assumption ($4314 vs $2700).
Furthermore, the model assumed only a 1 year time
frame, and this may underestimate the long-term total
benefits and costs; in particular, the studies were only
able to capture revision rates at 1 year. There is a possi-
bility of revision or even re-revision beyond 1 year which
will affect the long-term costs and health-related quality
of life. Literature demonstrates that the incidence of re-
vision is higher in patients who have had one revision
compared to those that have not failed. In this case, if
the time intervals were extended, potentially more
benefits would be seen for the intervention with better
revision rates. However, we cannot quantify this benefit
due to the lack of information in the published studies
that were included in the analysis.
This study was carried out from the perspective of the
US healthcare payer’s system and used average Medicare
reimbursement as a proxy for the hospital costs. We wish
to highlight two issues with this approach. Firstly, we are
aware that there are some patients who do not fall under
Medicare, and, secondly, the US costs may not be applic-
able in other healthcare systems. In the case of Medicare
patients, there is a possibility that the total costs are
underestimated, as Medicare usually negotiates lower
costs than other payers, while the use of US costs tend to
overestimate savings in other healthcare jurisdictions. We
therefore suggest caution when interpreting these results
in other healthcare systems, and encourage the use of
local costs to test the robustness of our findings on a local
basis. We suggest that the economic analysis should also
be performed using different perspectives such as the soci-
etal to capture all possible long-term costs and benefits.
Conclusion
In addition to other factors such as fracture type, pre- and
postoperative morbidity of the patient and individual skills
of the surgeon, this economic evaluation will assist decision
makers to make choices that will optimise outcomes while
accounting for differences in costs and uncertainty about
the different interventions assessed. The analysis supports
the use of the ITCS nail compared to standard of care
(single helical blade and single lag screw nails in managing
patients with unstable intertrochanteric fractures). These
findings remained robust when different assumptions were
tested. Studies with a longer time horizon maybe needed to
confirm if the benefits persist beyond the reported 1 year
and also include outcomes of possible conversion to total
Table 5 Sub-group analysis results: the ITCS nail compared to single lag screw nail
Intervention Costs Complications avoided QALYs Cost savings
Single lag screw $36,024 0.69 0.476
Integrated compression screw $34,373 0.78 0.546 $1652
Abbreviation: QALYs quality-adjusted life years
Table 6 Sub-group analysis results: the ITCS nail compared to
single helical blade nail
Intervention Costs Complications avoided QALYs 1Cost savings
Single helical
blade screw
$37,735 0.65 0.442
Integrated
compression
screw
$34,455 0.78 0.543 $3280
Abbreviation: QALYs quality-adjusted life years
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hip replacement for patients whose implants fail at 1 year.
Clinicians and policy makers should be encouraged to
adopt healthcare technologies such as ITCS that will help
them to provide quality healthcare despite falling budgets.
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